Orphan Drug Designations (ODD)
The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) provide specific incentives to companies who are granted ODD for their product.
BlueReg can determine if your product is eligible for orphan drug designation and provide the necessary support for your European Medicines Agency (EMA) / Food and Drug Administration (FDA) application.
Our experts
Our team can also support you through the entire application process from development, to registration and post-approval management
Marie-Caroline Leclere 
Nadia Boehringer 
Associated News